Welcome to LookChem.com Sign In|Join Free

CAS

  • or

138402-05-8

Post Buying Request

138402-05-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

138402-05-8 Usage

Description

2-N-Butyl-1,3-Diazaspiro[4,4]Non-1-En-4-One Hydrochloride is an organic compound that serves as an intermediate in the synthesis of pharmaceuticals. It is characterized by its oil-like chemical properties, which may contribute to its solubility and reactivity in various chemical processes.

Uses

Used in Pharmaceutical Industry:
2-N-Butyl-1,3-Diazaspiro[4,4]Non-1-En-4-One Hydrochloride is used as a chemical intermediate for the production of Irbesartan (Avapro) (I751000), which is a medication used to treat high blood pressure and type 2 diabetes. Its role in the synthesis process is crucial for the development of this medication, as it contributes to the overall structure and function of the final product.

Check Digit Verification of cas no

The CAS Registry Mumber 138402-05-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,4,0 and 2 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 138402-05:
(8*1)+(7*3)+(6*8)+(5*4)+(4*0)+(3*2)+(2*0)+(1*5)=108
108 % 10 = 8
So 138402-05-8 is a valid CAS Registry Number.
InChI:InChI=1/C11H18N2O/c1-2-3-6-9-12-10(14)11(13-9)7-4-5-8-11/h2-8H2,1H3,(H,12,13,14)

138402-05-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one

1.2 Other means of identification

Product number -
Other names DIA002

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:138402-05-8 SDS

138402-05-8Relevant articles and documents

OMS-2 nanorod-supported cobalt catalyst for aerobic dehydrocyclization of vicinal diols and amidines: Access to functionalized imidazolones

Xie, Feng,Chen, Xiuwen,Zhang, Xiangyu,Luo, Chujun,Lin, Shizhuo,Chen, Xiaoyong,Li, Bin,Li, Yibiao,Zhang, Min

, p. 192 - 197 (2021/05/17)

The development of reusable base metal catalysts for innovative catalytic transformations is a key technology toward sustainable production of fine chemicals, pharmaceuticals, and other function products. Herein, we report the preparation of a new highly dipersed manganese oxides of octahedral molecular sieve (OMS-2) nanorod-supported cobalt catalyst, which is successfully applied for aerobic dehydrocyclization of vicinal diols and amidines to access structurally diverse imidazolones, a class of valuable compounds found in numerous natural and biomedical products. The developed catalytic transformation proceeds with broad substrate scope, good functional group compability, the use of green molecular oxygen and reusable cobalt catalyst, which offers an important platform for the conversion of abundant and sustainable alcohol resources into functional N-heterocycles. The strategy combining nanocatalyst design with aerobic dehydrocoupling is anticipated to achieve other challenging catalytic transformations.

Synthesis of 2-Aminoimidazolones and Imidazolones by (3 + 2) Annulation of Azaoxyallyl Cations

DiPoto, Maria C.,Wu, Jimmy

, p. 499 - 501 (2018/02/09)

The first examples of (3 + 2) annulations between azaoxyallyl cations and cyanamides and nitriles to give the corresponding 2-aminoimidazolones and imidazolones are reported. On the basis of the isolation of unexpected imidate products with certain substr

SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES

-

Page/Page column 38, (2010/02/16)

The present invention relates to polysubstituted imidazolone derivatives, to the pharmaceutical compositions comprising them and to the therapeutic uses thereof in the human and animal health fields. The present invention also relates to a process for preparing these derivatives.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 138402-05-8